glp-1 2026 Medicaid Coverage of and Spending on GLP-1s GLP-1 prescription trends through March

Lilly plans regulatory submissions in 2025 for obesity and in 2026 for type 2 diabetes

After years of research, we finally understand how GLP-1s impact T on day 1 versus years later.

These wellness patches are intended to support your overall healthy lifestyle and are not intended to diagnose, treat, cure, or prevent any disease

Exploring the interaction between cannabis use and GLP-1 medications like Ozempic or Wegovy

Sales of antiobesity drugs hit $1.1 billion in the second quarter of 2023.

And, Changing patterns of contraceptive use show routine contraception utilization down by 3% in 2023, and at the same time, emergency contraception use and sterilization visits up 35% and 11%, respectively